[1] SU W P, HO Y C, WU C K, et al. Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways [J]. Sci Rep, 2017, 7(1): 3879.
[2] HUANG M, D'ANDREA A D. A new nuclease member of the FAN club [J]. Nat Struct Mol Biol, 2010, 17(8): 926-928.
[3] LEUNG J W, WANG Y C, FONG K W, et al. Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair[J]. Proc Nat Acad Sci U S A, 2012, 109(12):4491-4496.
[4] BHATTACHARJEE S, NANDI S. DNA damage response and cancer therapeutics through the lens of the Fanconi anemia DNA repair pathway [J]. Cell Commu Signal, 2017, 15(1):41.
[5] GEISELHART A, LIER A, WALTER D, et al. Disrupted signaling through the Fanconi anemia pathway leads to dysfunctional hematopoietic stem cell biology: underlying mechanisms and potential therapeutic strategies[J]. Anemia, 2012. DOI: 10.1155/2012/265790.
[6] D'ANDREA A D. BRCA1: a missing link in the Fanconi anemia/BRCA pathway[J]. Cancer Discov, 2013, 3(4):376-378.
[7] MANI C, TRIPATHI K, CHAUDHARY S, et al. Hedgehog/GLI1 transcriptionally regulates FANCD2 in ovarian tumor cells: its inhibition induces HR-deficiency and synergistic lethality with PARP inhibition [J]. Neoplasia, 2021, 23(9):1002-1015.
[8] BROSH R M, BELLANI M, LIU Y, et al. Fanconi anemia: a DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging[J]. Ageing Res Rev, 2017, 17(16):67-75.
[9] HELBLING-LECLERC A, GARCIN C, ROSSELLI F. Beyond DNA repair and chromosome instability—Fanconi anaemia as a cellular senescence-associated syndrome[J]. Cell Death Differ, 2021, 28(4):1159-1173.
[10] PANDAY A, WILLIS N A, ELANGO R, et al. FANCM regulates repair pathway choice at stalled replication forks[J]. Mol Cell, 2021, 81(11):2428-2444.
[11] CICCIA A, CHEN L, COULTHARD R, et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM[J]. Mol Cell, 2007, 25(3):331-343.
[12] HUANG M, KIM J M, SHIOTANI B, et al. The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response[J]. Mol Cell, 2010, 39(2):259-268.
[13] SCHWAB R A, BLACKFORD A N, NIEDZWIEDZ W. ATR activation and replication fork restart are defective in FANCM-deficient cells[J]. EMBO J, 2014, 29(4):806-818.
[14] POLITO D, CUKRAS S, WANG X Z, et al. The carboxyl terminus of FANCE recruits FANCD2 to the Fanconi anemia (FA) E3 ligase complex to promote the FA DNA repair pathway[J]. J Biol Chem, 2014, 289(10):7003-7010.
[15] SWUEC P, RENAULT L, BORG A, et al. The FA core complex contains a homo-dimeric catalytic module for the symmetric mono-ubiquitination of FANCI-FANCD2 [J]. Cell Rep, 2017, 18(3):611-623.
[16] DUBOIS E L, LAURE G S, MARILINE B, et al. A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2 [J]. Nucleic Acids Res, 2019, (14):7532-7547.
[17] WALDEN H, RENNIE M L, LEMONIDIS K, et al. Differential functions of FANCI and FANCD2 ubiquitination stabilize ID2 complex on DNA[J]. EMEO Rep, 2020, 21(7):e50133.
[18] WANG R, WANG S, DHAR A, et al. DNA clamp function of the monoubiquitinated Fanconi anaemia ID complex[J]. Nature, 2020, 580(7802): 278-282.
[19] LIANG C C, LI Z L, LOPEZ-MARTINEZ D, et al. The FANCD2-FANCI complex is recruited to DNA interstrand crosslinks before monoubiquitination of FANCD2 [J]. Nature Commu, 2016, 7:12124.[20] LONGERICH S, LI J, XIONG Y, et al. Stress and DNA repair biology of the Fanconi anemia pathway[J]. Blood, 2014, 124(18):2812-2819.
[21] KIM H, D'ANDREA A D. Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway[J]. Genes Dev, 2012, 26(13)1393-1408.
[22] RENAUDIN X, ROSSELLI F. The FANC/BRCA pathway releases replication blockades by eliminating DNA interstrand cross-links[J]. Genes, 2020, 11(5):585.
[23] OESTERGAARD V H, LANGEVIN F, KUIKEN H J, et al. Deubiquitination of FANCD2 is required for DNA crosslink repair[J]. Mol Cell, 2007, 28(5):798-809.
[24] HOSOYA N, MIYAGAWA K. Targeting DNA damage response in cancer therapy[J]. Cancer Sci, 2014, 105(4):370-388.
[25] QIN C J, SONG X M, CHEN Z H, et al. XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy[J]. Oncotarget, 2015, 6(31):32193-32204.
[26] XU G, CHAPMAN J R, BRANDSMA I, et al. REV7 counteracts DNA double-strand break resection and affects PARP inhibition[J]. Nature, 2015, 521(7553):541-544.
[27] SARKAR J, LIU Y. Fanconi anemia proteins in telomere maintenance[J]. DNA Repair: Amst, 2016, 43:107-112.
[28] DOMINGUES-SILVA B, SILVA B, AZZALIN C M. ALTernative functions for human FANCM at telomeres[J]. Front Mol Biosci, 2019, 6:84.
[29] RHEE D B, WANG Y, MIZESKO M, et al. FANCC suppresses short telomere-initiated telomere sister chromatid exchange[J]. Hum Mol Genet, 2010, 19(5):879-887.
[30] JOKSIC I, VUJIC D, GUC-SCEKIC M, et al. Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients[J]. Genome Integr, 2012, 3(1):6. |
